Strategies for Suspected Pulmonary Embolism in Emergency Departments

This study has been completed.
Sponsor:
Collaborator:
Ministry of Health, France
Information provided by:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT00188032
First received: September 12, 2005
Last updated: February 4, 2009
Last verified: February 2009
  Purpose

Aims: 1) To evaluate the effectiveness of two interventions aimed at improving the management of patients with suspected pulmonary embolism: Written guidelines and Computer-Assisted Decision Support (CADS). 2) To evaluate the impact of electronic reminders on the appropriateness of the treatment of patients with suspected PE

Design: Pragmatic, unblinded, cluster randomised controlled study.

Setting: 20 French Emergency Departments

Patients: Out patients suspected of having pulmonary embolism

Methods: Emergency physicians will prospectively complete a standardized electronic form on Personal Data Assistant (PDA), including patients' characteristics, the clinical probability if assessed, the diagnostic tests performed, the treatments initiated and the final diagnostic and therapeutic decisions. Patients will be interviewed at the end of a 3-month follow-up period using a standardized questionnaire.

The reference rate of appropriateness of the diagnostic management before intervention will be assessed in each centre. At the end of this preliminary period, the centres will be randomized in two fold two groups according to a factorial design with stratification on their reference level of appropriateness. Half of the centres will have written guidelines and half a Computer-Assisted Decision Support for the diagnosis of PE on the PDA. In each of these two main groups, half of the centres will have electronic reminders on their PDA concerning the treatment of PE.

Judgment criteria

Main : Rate of strategies considered as validated according to the results of the systematic review and meta-analysis.3

Secondary judgment criteria (diagnosis):

  • Rate of strategies considered as validated or acceptable according to the opinion of international advisors.
  • Rate of thromboembolic-events during a 3-month follow-up period in patients for whom pulmonary embolism will be ruled out
  • Costs of the diagnostic management

Secondary judgment criteria (treatment):

  • Delay between Emergency Department admission and the first dose of antithrombotic treatment in patients with high clinical probability of PE according to the Revised Geneva Score
  • Rate of inappropriate treatment according to international recommendations for patients with confirmed PE.

Number of patients: By estimating that the rate of appropriateness would be 55% in the "written guidelines" group, 1331 patients are necessary to highlight an absolute superiority of 15% in the "CADS" group (rate of conformity of 70%).

The number of patients will be adjusted at the end of the preliminary period according to the level of appropriateness before interventions considering that it will improve less than 5% in the "written guidelines" group.


Condition Intervention
Quality of Health Care
Pulmonary Embolism
Procedure: Computer-Assisted diagnostic Decision Support
Procedure: written diagnostic guidelines
Procedure: electronic therapeutic reminders

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Strategies for Suspected Pulmonary Embolism in Emergency Departments - SPEED Study

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:
  • rate of agreement between the diagnostic criteria applied in daily practice and those validated in the scientific literature

Secondary Outcome Measures:
  • -(diagnostic intervention) Rate of strategies considered as validated or acceptable according to the opinion of international advisors.
  • - (diagnostic intervention) Rate of thromboembolic-events during a 3-month follow-up period in patients for whom pulmonary embolism will be ruled out
  • - (diagnostic intervention) Costs of the diagnostic management
  • - (therapeutic reminders) Delay between Emergency Department admission and the first dose of antithrombotic treatment in patients with high clinical probability of PE according to the Revised Geneva Score
  • - (therapeutic reminders)Rate of inappropriate treatment according to international recommendations for patients with confirmed PE.

Estimated Enrollment: 1331
Study Start Date: June 2005
Study Completion Date: September 2006
Detailed Description:

Background: The management of patients with suspected pulmonary embolism (PE) represents an important medical and economic issue. In French Emergency Departments, more than 100 000 suspicions of PE are dealt with per year. In a previous work, we found that the routine diagnostic practice differs to a large extent from international guidelines and that excluding PE on the basis of inappropriate criteria exposes patients to a six-fold increased risk of venous thromboembolism during 3-months follow-up.1 Passive interventions to improve quality are generally ineffective but Computer-Assisted Decision Support and reminders appear as promising.2

Interventions:

At the end of the preliminary period, we will perform for all the investigators, an interactive oral presentation of the strategies considered as validated on the basis of a systematic review and meta-analysis.3 A strategy end up to exclude PE is considered as validated if the probability of PE is below 5% and a strategy end up to confirm PE is considered as validated if the probability of PE is upper than 85%. The strategies that do not achieve these criteria but considered as acceptable by international advisors will be presented too as well as the recommendations for the treatment of PE.4 In the group "written guidelines", emergency physicians will be provided with cards presenting the list of the validated and acceptable strategies as well as the Geneva diagnostic algorithm.5 The algorithm will be mention as a way to follow appropriate diagnostic criteria.

In the "CADS" group, the recommendations will be integrated into the electronic form allowing calculation of the pre-test probability according to revised Geneva Score 6, calculation of the post-test probabilities according to the likelihood ratios of the tests 3 and contextualized reminders as which test perform or when stop investigations.

In the groups "treatment help", reminders concerning the treatment (indications and contraindications, dosage) will be integrated into the electronic form on the PDA.

  1. Roy PM, Meyer G, Vielle B, Legall C, Verschuren F, Furber A. Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome. J Thromb Haemost 2005; 3:OR 304.
  2. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care 2001; 39:II2-45.
  3. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. Bmj 2005; 331:259.
  4. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:401S-428S.
  5. Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116:291-9.
  6. Le Gal G, Righini M, Roy PM, et al. Derivation and validation of a simple standardized clinical score to predict pulmonary embolism in emergency patients: the revised geneva score. Ann Intern Med 2005; In press.
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient with suspected pulmonary embolism
  • prescription of a specific paraclinical diagnostic investigation or start of a specific treatment for pulmonary embolism

Exclusion Criteria:

  • confirmation or exclusion of pulmonary embolism before admission in emergency department
  • confirmation of deep venous thrombosis before admission in emergency department
  • suspicion of pulmonary embolism during hospitalization (in-patient)
  • suspicion of pulmonary embolism without investigation realization
  • patient already included in the study
  • patient refusing the utilization of his data for the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188032

Locations
France
H Argenteuil
Argenteuil, France, 95107
UH Besançon
Besançon, France, 25000
H Bethune
Bethune, France, 62408
UH Ambroise Pare
Boulogne Billancourt, France, 92100
UH Caen
Caen, France, 14033
H Chalons en Champagne
Chalons-en-Champagne, France, 51005
H Chateauroux
Chateauroux, France, 36019
H Compiegne
Compiegne, France, 60200
UH Dijon
Dijon, France, 21033
H Dreux
Dreux, France, 28107
UH Grenoble
Grenoble, France, 38043
H Langres
Langres, France, 52200
H le Mans
Le Mans, France, 72037
H Lons le Saunier
Lons le Saunier, France, 39016
UH Nancy
Nancy, France, 54035
UH La Pitie Salpetriere
Paris, France, 75651
H Roanne
Roanne, France, 42328
H Saint Nazaire
Saint Nazaire, France, 44606
H Thouars
Thouars, France, 79100
UH Toulouse
Toulouse, France, 31059
Sponsors and Collaborators
University Hospital, Angers
Ministry of Health, France
Investigators
Principal Investigator: Pierre-Marie Roy, MD, PhD UH Angers
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00188032     History of Changes
Other Study ID Numbers: PHRC-04-01
Study First Received: September 12, 2005
Last Updated: February 4, 2009
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Angers:
pulmonary embolism
clinical practice
quality of health care
diagnostic criteria
Computer-Assisted Decision Support
reminders

Additional relevant MeSH terms:
Embolism
Pulmonary Embolism
Cardiovascular Diseases
Embolism and Thrombosis
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 22, 2014